Synthetic Biologics (SYN) Misses Q1 EPS by 9c

Synthetic Biologics (NYSE: SYN) reported Q1 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c